Posts From Andrew Wright

Andrew Wright

Prior to founding tradersasset.com in 2014, Andrew worked as a proprietary trader, then as a market maker. As a market maker, he traded options in over 100 stocks, he then began trading currency pairs in 2013. Andrew still actively trades both, and prides himself on educating and informing traders on the benefits of both Binary Options and Forex.

Greenback Up on Strong Housing, Low Jobless Claim Data

  Higher than expected inflation rate in January and Q4 GDP growth of 2.9% (versus estimates of 1.8%) strengthened the Singapore dollar against the Greenback in mid-February. Lack of sufficient hawkishness at the US Fed also acted as a catalyst

Read More

Fiat Misses Q4 EPS Estimates, Faces EPA Investigation

  Despite posting an increase in the fiscal 2016 fourth-quarter revenue, compared with last year, the stock of automaker Fiat Chrysler Automobiles N.V. (NYSE: FCAU) has so far appreciated only by about 5% to $11.38. One of the reasons for

Read More

Pound Weakens as EU Prioritises Exit Bill Negotiations

  Considering the weak lending data announced by the Bank of England and soft retail spending in December, we had recommended taking a short position at 142.50 levels in the GBPJPY pair on February 1st, with a target price of

Read More

Rio Tinto Swings to Profit in FY16, Beats Earnings View

  In the second week of February, mining giant Rio Tinto Plc (NYSE: RIO) reported a decline in the fiscal 2016 revenue, compared with last year. However, the stock hit a 12-month high of $47.11. The main reason for the

Read More

Novartis Misses Q4 Rev. View, Issues Flat FY17 Outlook

  Since reporting fiscal 2016 fourth-quarter earnings that beat analysts’ estimates, the stock of Pharmaceutical company Novartis Ag (NYSE: NVS) has risen by 5% to $77.20 (as of Monday). Ironically, the company’s Q4 revenue was below analysts’ expectations. Analysts attribute

Read More

Greenback Strengthens on Strong Building Permit Data

  Soft wage growth, marginally higher-than-anticipated unemployment rate, and decline in the UoM (University of Michigan) consumer sentiment reading (preliminary) weakened the US dollar against the Russian Ruble in early February. The USDRUB pair’s downtrend was also aided by a

Read More

Teva Beats 4Q16 Estimates, Reaffirms FY17 EPS View

  World’s largest generic drug manufacturer Teva Pharmaceutical Industries Ltd (NYSE: TEVA) had missed its own earning guidance in the second and third-quarter of fiscal 2016. This had kept investors on edge during the latest quarter. Fortunately, on Monday, the

Read More

Yen Signals Weakness on Soft Preliminary GDP Growth

  The news of an increase in support for the anti-EU leader Marine Le Pen in the latest French election survey heightened concerns of political uncertainty in the EU. This encouraged speculators to go short in the Euro dollar, while

Read More

BP Misses 4Q16 Underlying Replacement Profit Estimates

  Last week, the “supermajor” oil company BP Plc (NYSE: BP) reported a swing to profit in the fiscal 2016 fourth-quarter, compared with a net loss in the similar quarter of fiscal 2015. The company also reported a y-o-y increase

Read More

Coca-Cola Beats 4Q16 View, Issues Soft FY17 Rev Outlook

  Despite beating Zacks earnings and revenue estimates for fiscal 2016 fourth-quarter, the stock of food and beverage company Coca-Cola Company (NYSE: KO) has lost about 5% in the past three trading sessions to close at $40.62 on Monday. While

Read More